MedTrace Logo

Influence of a New Polycationic Disinfectant on Clostridium Difficile Incidence and Environmental Colonisation

NCT00566306 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2008-08-26

No results posted yet for this study

Summary

The aim of this study is to 1) test the efficacy of PHMG-based disinfectant against C. difficile spores, 2) test whether it reduces the incidence of C. difficile associated disease (CDAD) and 3) evaluate cost.

Conditions

  • Clostridium Difficile

Interventions

OTHER

Polyhexamethyleneguanidine (PHMG)

6 months in 3 experimental wards

Sponsors & Collaborators

  • Soft Protector

    collaborator INDUSTRY

  • The Finnish Funding Agency for Technology and Innovation (TEKES)

    collaborator OTHER_GOV

  • University of Helsinki

    lead OTHER

Principal Investigators

  • Mari Kanerva, MD,PhD · Helsinki University Central Hospital, Department of Medicine, Division of Infectious Diseases

Study Design

Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2008-06-30
Completion
2008-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00566306 on ClinicalTrials.gov